Dolutegravir plus lamivudine shows comparable efficacy and safety with standard-of-care three-drug regimen in patients with ...
The tumult of large-scale cuts to federal spending, pullbacks of civil rights protections, and new tariffs getting announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback